Myosin Therapeutics

BiotechnologySeedJupiter, USmyosintherapeutics.com

Latest round

Seed

Last raised

Mar 2025

Total raised

$6M

Investors

7

About Myosin Therapeutics

, operates as a developer of novel pharmacotherapies targeting members of the myosin family of molecular motors. In March 2026, Myosin Therapeutics Inc. The company offers various biopharmaceutical solutions that include novel medications targeting cellular motor proteins, and specialized molecular machines that convert energy into mechanical work inside cells. The company's proprietary nMotor system for drug discovery is a full screening platform that enables Myosin to develop a robust pipeline used for the treatment of disorders including cancer, neural regeneration, and other infectious diseases.

Who invested in Myosin Therapeutics

7 investors across 2 rounds

See all investors in Myosin Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Mar 3, 2025

    Amount

    $3M

    Investors

    Locked

  2. Seed

    Dec 2, 2022

    Amount

    $3M

    Investors

    Locked

Questions about Myosin Therapeutics

Who invested in Myosin Therapeutics?

Myosin Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Myosin Therapeutics raised?

Myosin Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Myosin Therapeutics last raise money?

Myosin Therapeutics's most recent round on record is a Seed, in Mar 2025.

What does Myosin Therapeutics do?

, operates as a developer of novel pharmacotherapies targeting members of the myosin family of molecular motors.

Where is Myosin Therapeutics headquartered?

Myosin Therapeutics is headquartered in Jupiter, US.

Which VCs invest in companies like Myosin Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Myosin Therapeutics's stage. Their profiles are linked below.

Raising like Myosin Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.